Report Detail
Global Medical Asparaginase Market Growth 2019-2024
- RnM2925030 |
- 11 February, 2019 |
- Global |
- 139 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available.
Asparaginase was approved for medical use in the United States in 1978. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
The classification of Medical Asparaginase includes Escherichia coli, Erwinia Chrysanthemi and Pegylated, and the sales proportion of Escherichia coli in 2017 is about 64.6%, and the proportion is decreasing trend from 2013 to 2018.
Medical Asparaginase is widely sales for Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia and Others. The most proportion of Medical Asparaginase is sales in Acute Lymphoblastic Leukemia, and the consumption proportion is about 90% in 2017.
North America is the largest consumption place, with a revenue market share nearly 53.5% in 2017. Following North America, Europe is the second largest consumption place with the revenue market share of 37.2%, China is also an important sales region for the Medical Asparaginase, In China, the price is lower than the developed countries.
Market competition is intense. Jazz Pharmaceuticals, Shire, Medac GmbH, Kyowa Hakko Kirin, etc. are the leaders of the industry. They hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.
According to this study, over the next five years the Medical Asparaginase market will register a 1.5% CAGR in terms of revenue, the global market size will reach US$ 430 million by 2024, from US$ 390 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Medical Asparaginase business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Asparaginase market by product type, application, key manufacturers and key regions and countries.
This study considers the Medical Asparaginase value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Escherichia coli
Erwinia Chrysanthemi
Pegylated
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Jazz Pharmaceuticals
Shire
Medac GmbH
Kyowa Hakko Kirin
Qianhong Bio-pharma
Taj Pharmaceuticals
Mingxing Pharma
SL Pharma
United Biotech
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Medical Asparaginase consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Medical Asparaginase market by identifying its various subsegments.
Focuses on the key global Medical Asparaginase manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Medical Asparaginase with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Medical Asparaginase submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Medical Asparaginase Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Medical Asparaginase Consumption 2014-2024
- 2.1.2 Medical Asparaginase Consumption CAGR by Region
- 2.2 Medical Asparaginase Segment by Type
- 2.2.1 Escherichia coli
- 2.2.2 Erwinia Chrysanthemi
- 2.2.3 Pegylated
- 2.3 Medical Asparaginase Consumption by Type
- 2.3.1 Global Medical Asparaginase Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Medical Asparaginase Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Medical Asparaginase Sale Price by Type (2014-2019)
- 2.4 Medical Asparaginase Segment by Application
- 2.4.1 Acute Lymphoblastic Leukemia
- 2.4.2 Acute Myeloid Leukemia
- 2.4.3 Other
- 2.5 Medical Asparaginase Consumption by Application
- 2.5.1 Global Medical Asparaginase Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Medical Asparaginase Value and Market Share by Application (2014-2019)
- 2.5.3 Global Medical Asparaginase Sale Price by Application (2014-2019)
3 Global Medical Asparaginase by Players
- 3.1 Global Medical Asparaginase Sales Market Share by Players
- 3.1.1 Global Medical Asparaginase Sales by Players (2017-2019)
- 3.1.2 Global Medical Asparaginase Sales Market Share by Players (2017-2019)
- 3.2 Global Medical Asparaginase Revenue Market Share by Players
- 3.2.1 Global Medical Asparaginase Revenue by Players (2017-2019)
- 3.2.2 Global Medical Asparaginase Revenue Market Share by Players (2017-2019)
- 3.3 Global Medical Asparaginase Sale Price by Players
- 3.4 Global Medical Asparaginase Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Medical Asparaginase Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Medical Asparaginase Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Medical Asparaginase by Regions
- 4.1 Medical Asparaginase by Regions
- 4.1.1 Global Medical Asparaginase Consumption by Regions
- 4.1.2 Global Medical Asparaginase Value by Regions
- 4.2 Americas Medical Asparaginase Consumption Growth
- 4.3 APAC Medical Asparaginase Consumption Growth
- 4.4 Europe Medical Asparaginase Consumption Growth
- 4.5 Middle East & Africa Medical Asparaginase Consumption Growth
5 Americas
- 5.1 Americas Medical Asparaginase Consumption by Countries
- 5.1.1 Americas Medical Asparaginase Consumption by Countries (2014-2019)
- 5.1.2 Americas Medical Asparaginase Value by Countries (2014-2019)
- 5.2 Americas Medical Asparaginase Consumption by Type
- 5.3 Americas Medical Asparaginase Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Medical Asparaginase Consumption by Countries
- 6.1.1 APAC Medical Asparaginase Consumption by Countries (2014-2019)
- 6.1.2 APAC Medical Asparaginase Value by Countries (2014-2019)
- 6.2 APAC Medical Asparaginase Consumption by Type
- 6.3 APAC Medical Asparaginase Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Medical Asparaginase by Countries
- 7.1.1 Europe Medical Asparaginase Consumption by Countries (2014-2019)
- 7.1.2 Europe Medical Asparaginase Value by Countries (2014-2019)
- 7.2 Europe Medical Asparaginase Consumption by Type
- 7.3 Europe Medical Asparaginase Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Medical Asparaginase by Countries
- 8.1.1 Middle East & Africa Medical Asparaginase Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Medical Asparaginase Value by Countries (2014-2019)
- 8.2 Middle East & Africa Medical Asparaginase Consumption by Type
- 8.3 Middle East & Africa Medical Asparaginase Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Medical Asparaginase Distributors
- 10.3 Medical Asparaginase Customer
11 Global Medical Asparaginase Market Forecast
- 11.1 Global Medical Asparaginase Consumption Forecast (2019-2024)
- 11.2 Global Medical Asparaginase Forecast by Regions
- 11.2.1 Global Medical Asparaginase Forecast by Regions (2019-2024)
- 11.2.2 Global Medical Asparaginase Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Medical Asparaginase Forecast by Type
- 11.8 Global Medical Asparaginase Forecast by Application
12 Key Players Analysis
- 12.1 Jazz Pharmaceuticals
- 12.1.1 Company Details
- 12.1.2 Medical Asparaginase Product Offered
- 12.1.3 Jazz Pharmaceuticals Medical Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Jazz Pharmaceuticals News
- 12.2 Shire
- 12.2.1 Company Details
- 12.2.2 Medical Asparaginase Product Offered
- 12.2.3 Shire Medical Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Shire News
- 12.3 Medac GmbH
- 12.3.1 Company Details
- 12.3.2 Medical Asparaginase Product Offered
- 12.3.3 Medac GmbH Medical Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Medac GmbH News
- 12.4 Kyowa Hakko Kirin
- 12.4.1 Company Details
- 12.4.2 Medical Asparaginase Product Offered
- 12.4.3 Kyowa Hakko Kirin Medical Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Kyowa Hakko Kirin News
- 12.5 Qianhong Bio-pharma
- 12.5.1 Company Details
- 12.5.2 Medical Asparaginase Product Offered
- 12.5.3 Qianhong Bio-pharma Medical Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Qianhong Bio-pharma News
- 12.6 Taj Pharmaceuticals
- 12.6.1 Company Details
- 12.6.2 Medical Asparaginase Product Offered
- 12.6.3 Taj Pharmaceuticals Medical Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Taj Pharmaceuticals News
- 12.7 Mingxing Pharma
- 12.7.1 Company Details
- 12.7.2 Medical Asparaginase Product Offered
- 12.7.3 Mingxing Pharma Medical Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Mingxing Pharma News
- 12.8 SL Pharma
- 12.8.1 Company Details
- 12.8.2 Medical Asparaginase Product Offered
- 12.8.3 SL Pharma Medical Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 SL Pharma News
- 12.9 United Biotech
- 12.9.1 Company Details
- 12.9.2 Medical Asparaginase Product Offered
- 12.9.3 United Biotech Medical Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 United Biotech News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Medical Asparaginase . Industry analysis & Market Report on Medical Asparaginase is a syndicated market report, published as Global Medical Asparaginase Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Medical Asparaginase market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
